24 Apr 2025
PBAC Public Summary Documents (first time decisions not to recommend and deferrals) – December 2024 meeting
PBAC Public Summary Documents (first time decisions not to recommend and deferrals) – December 2024 meeting
24 Apr 2025
Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) – March 2025
Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) – March 2025
17 Apr 2025
Pharmaceutical Benefits Scheme (PBS) Safety Net Threshold changes
Pharmaceutical Benefits Scheme (PBS) Safety Net Threshold changes
14 Apr 2025
New Online Portal & Info Sheet: Stay Compliant with Minimum Stockholding Requirements
New Online Portal & Info Sheet: Stay Compliant with Minimum Stockholding Requirements
09 Apr 2025
New Minimum Stockholding Requirements Online Notification Portal and Fact Sheet
New Minimum Stockholding Requirements Online Notification Portal and Fact Sheet
01 Apr 2025
Expanded access to empagliflozin for type 2 diabetes patients with high cardiovascular risk
Expanded access to empagliflozin for type 2 diabetes patients with high cardiovascular risk
01 Apr 2025
Hormone Replacement Therapy (HRT) Patch Shortages: PBS Subsidy Updates & Substitution Options for Estradot, Estraderm MX, and Overseas Alternatives
Shortages of hormone replace therapy (HRT) patches: PBS subsidy and substitution of Estradot, Estraderm MX and overseas alternatives
01 Apr 2025
1 April 2025 designated brand list – minimum stockholding requirements
1 April 2025 designated brand list – minimum stockholding requirements